Cargando…

New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research

Diabetes mellitus is associated with defects in islet β-cell functioning and consequent hyperglycemia resulting in multi-organ damage. Physiologically relevant models that mimic human diabetic progression are urgently needed to identify new drug targets. Three-dimensional (3D) cell-culture systems a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohandas, Sundhar, Gayatri, Vijaya, Kumaran, Kriya, Gopinath, Vipin, Paulmurugan, Ramasamy, Ramkumar, Kunka Mohanram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056755/
https://www.ncbi.nlm.nih.gov/pubmed/36986591
http://dx.doi.org/10.3390/pharmaceutics15030725
_version_ 1785016201292808192
author Mohandas, Sundhar
Gayatri, Vijaya
Kumaran, Kriya
Gopinath, Vipin
Paulmurugan, Ramasamy
Ramkumar, Kunka Mohanram
author_facet Mohandas, Sundhar
Gayatri, Vijaya
Kumaran, Kriya
Gopinath, Vipin
Paulmurugan, Ramasamy
Ramkumar, Kunka Mohanram
author_sort Mohandas, Sundhar
collection PubMed
description Diabetes mellitus is associated with defects in islet β-cell functioning and consequent hyperglycemia resulting in multi-organ damage. Physiologically relevant models that mimic human diabetic progression are urgently needed to identify new drug targets. Three-dimensional (3D) cell-culture systems are gaining a considerable interest in diabetic disease modelling and are being utilized as platforms for diabetic drug discovery and pancreatic tissue engineering. Three-dimensional models offer a marked advantage in obtaining physiologically relevant information and improve drug selectivity over conventional 2D (two-dimensional) cultures and rodent models. Indeed, recent evidence persuasively supports the adoption of appropriate 3D cell technology in β-cell cultivation. This review article provides a considerably updated view of the benefits of employing 3D models in the experimental workflow compared to conventional animal and 2D models. We compile the latest innovations in this field and discuss the various strategies used to generate 3D culture models in diabetic research. We also critically review the advantages and the limitations of each 3D technology, with particular attention to the maintenance of β-cell morphology, functionality, and intercellular crosstalk. Furthermore, we emphasize the scope of improvement needed in the 3D culture systems employed in diabetes research and the promises they hold as excellent research platforms in managing diabetes.
format Online
Article
Text
id pubmed-10056755
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100567552023-03-30 New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research Mohandas, Sundhar Gayatri, Vijaya Kumaran, Kriya Gopinath, Vipin Paulmurugan, Ramasamy Ramkumar, Kunka Mohanram Pharmaceutics Review Diabetes mellitus is associated with defects in islet β-cell functioning and consequent hyperglycemia resulting in multi-organ damage. Physiologically relevant models that mimic human diabetic progression are urgently needed to identify new drug targets. Three-dimensional (3D) cell-culture systems are gaining a considerable interest in diabetic disease modelling and are being utilized as platforms for diabetic drug discovery and pancreatic tissue engineering. Three-dimensional models offer a marked advantage in obtaining physiologically relevant information and improve drug selectivity over conventional 2D (two-dimensional) cultures and rodent models. Indeed, recent evidence persuasively supports the adoption of appropriate 3D cell technology in β-cell cultivation. This review article provides a considerably updated view of the benefits of employing 3D models in the experimental workflow compared to conventional animal and 2D models. We compile the latest innovations in this field and discuss the various strategies used to generate 3D culture models in diabetic research. We also critically review the advantages and the limitations of each 3D technology, with particular attention to the maintenance of β-cell morphology, functionality, and intercellular crosstalk. Furthermore, we emphasize the scope of improvement needed in the 3D culture systems employed in diabetes research and the promises they hold as excellent research platforms in managing diabetes. MDPI 2023-02-22 /pmc/articles/PMC10056755/ /pubmed/36986591 http://dx.doi.org/10.3390/pharmaceutics15030725 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mohandas, Sundhar
Gayatri, Vijaya
Kumaran, Kriya
Gopinath, Vipin
Paulmurugan, Ramasamy
Ramkumar, Kunka Mohanram
New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research
title New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research
title_full New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research
title_fullStr New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research
title_full_unstemmed New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research
title_short New Frontiers in Three-Dimensional Culture Platforms to Improve Diabetes Research
title_sort new frontiers in three-dimensional culture platforms to improve diabetes research
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056755/
https://www.ncbi.nlm.nih.gov/pubmed/36986591
http://dx.doi.org/10.3390/pharmaceutics15030725
work_keys_str_mv AT mohandassundhar newfrontiersinthreedimensionalcultureplatformstoimprovediabetesresearch
AT gayatrivijaya newfrontiersinthreedimensionalcultureplatformstoimprovediabetesresearch
AT kumarankriya newfrontiersinthreedimensionalcultureplatformstoimprovediabetesresearch
AT gopinathvipin newfrontiersinthreedimensionalcultureplatformstoimprovediabetesresearch
AT paulmuruganramasamy newfrontiersinthreedimensionalcultureplatformstoimprovediabetesresearch
AT ramkumarkunkamohanram newfrontiersinthreedimensionalcultureplatformstoimprovediabetesresearch